AI assistant
MANHATTAN ASSOCIATES INC — Director's Dealing 2012
Feb 23, 2012
30487_dirs_2012-02-23_507f6781-7a0f-485a-b761-ed2d8b0756aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANHATTAN ASSOCIATES INC (MANH)
CIK: 0001056696
Period of Report: 2012-02-21
Reporting Person: SINISGALLI PETER F (Director, President, CEO & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-21 | Common Stock | M | 33204 | $28.52 | Acquired | 146217 | Direct |
| 2012-02-21 | Common Stock | S | 33204 | $46.5216 | Disposed | 113013 | Direct |
| 2012-02-22 | Common Stock | M | 14830 | $28.52 | Acquired | 127843 | Direct |
| 2012-02-22 | Common Stock | S | 14830 | $46.5135 | Disposed | 113013 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-21 | Employee Stock Option | $28.52 | M | 33204 | Disposed | 2014-07-19 | Common Stock (33204) | Direct |
| 2012-02-22 | Employee Stock Option | $28.52 | M | 14830 | Disposed | 2014-07-19 | Common Stock (14830) | Direct |
Footnotes
F1: $46.5216 is the weighted average sale price for the transactions reported in this line item. These transactions were consummated at prices ranging from $46.5000 to $46.6050. The filing person undertakes to provide full information regarding the number of shares sold at each price upon request by the Securities and Exchange Commission, the Company or a security holder of the Company.
F2: $46.5135 is the weighted average sale price for the transactions reported in this line item. These transactions were consummated at prices ranging from $46.5000 to $46.5700. The filing person undertakes to provide full information regarding the number of shares sold at each price upon request by the Securities and Exchange Commission, the Company or a security holder of the Company.
F3: This option vested 6.25% per quarter for 4 years; original grant date was 07/19/07.